ATE197889T1 - Kontrolle des haarwuchses - Google Patents

Kontrolle des haarwuchses

Info

Publication number
ATE197889T1
ATE197889T1 AT95932057T AT95932057T ATE197889T1 AT E197889 T1 ATE197889 T1 AT E197889T1 AT 95932057 T AT95932057 T AT 95932057T AT 95932057 T AT95932057 T AT 95932057T AT E197889 T1 ATE197889 T1 AT E197889T1
Authority
AT
Austria
Prior art keywords
pct
hair growth
control hair
date mar
sec
Prior art date
Application number
AT95932057T
Other languages
English (en)
Inventor
Andrew Guy Messenger
Original Assignee
Univ Sheffield
Bio Scient Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9418484A external-priority patent/GB9418484D0/en
Priority claimed from GB9418547A external-priority patent/GB9418547D0/en
Application filed by Univ Sheffield, Bio Scient Ltd filed Critical Univ Sheffield
Application granted granted Critical
Publication of ATE197889T1 publication Critical patent/ATE197889T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95932057T 1994-09-14 1995-09-13 Kontrolle des haarwuchses ATE197889T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9418484A GB9418484D0 (de) 1994-09-14 1994-09-14
GB9418547A GB9418547D0 (en) 1994-09-15 1994-09-15 Control of hair growth
PCT/GB1995/002166 WO1996008231A1 (en) 1994-09-14 1995-09-13 Control of hair growth

Publications (1)

Publication Number Publication Date
ATE197889T1 true ATE197889T1 (de) 2000-12-15

Family

ID=26305622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932057T ATE197889T1 (de) 1994-09-14 1995-09-13 Kontrolle des haarwuchses

Country Status (10)

Country Link
US (1) US6020327A (de)
EP (1) EP0777458B1 (de)
JP (1) JPH10508828A (de)
AT (1) ATE197889T1 (de)
AU (1) AU705118B2 (de)
CA (1) CA2200085A1 (de)
DE (1) DE69519582D1 (de)
GB (1) GB2295088B (de)
NZ (1) NZ292940A (de)
WO (1) WO1996008231A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200978T1 (de) * 1996-03-29 2001-05-15 S W Patentverwertungs Ges M B KOSMETIKUM BZW. KOSMETIKZUSAMMENSETZUNG ZUR GLÄTTUNG UND STRAFFUNG DER HAUT BEI GESTÖRTEM UNTERHAUT-BINDE-FETTGEWEBE, INSBESONDERE BEI DER ßCELLULITEß
US20020086856A1 (en) 1998-03-18 2002-07-04 Alfred Schmidt Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
BR0013272B1 (pt) * 1999-08-13 2013-10-15 Uso de um inibidor de aromatase esteroidal
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
CZ20024214A3 (cs) 2000-06-28 2003-04-16 Bristol-Myers Squibb Company Selektivní androgen receptorový modulátor, způsob jeho identifikace, jeho konstrukce a použití
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (de) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
SE0004808D0 (sv) * 2000-12-20 2000-12-20 Apbiotech Ab Method for the purification of an enzyme
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
PL206962B1 (pl) * 2001-12-19 2010-10-29 Bristol Myers Squibb Co Związek heterocykliczny o budowie skondensowanej
US20060009430A1 (en) * 2004-07-01 2006-01-12 Kelly Gregory J Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
ES2574933T3 (es) * 2007-11-13 2016-06-23 Athenion Ag Esteroides de C-19 para usos cosméticos
DE102008012988A1 (de) * 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
JP2011026240A (ja) * 2009-07-24 2011-02-10 Api Co Ltd 花粉荷を含有する育毛剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2840144A1 (de) * 1978-09-15 1980-03-27 Goedecke Ag Topisch applizierbares arzneimittel mit antiandrogener wirkung
DE3486090T2 (de) * 1983-12-12 1993-08-05 Kaszynski Edwin G Haarwuchsmodifikation.
US5053403A (en) * 1984-05-11 1991-10-01 Norman Orentreich Methods for treatment of male-pattern baldness
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
GB8413070D0 (en) * 1984-05-22 1984-06-27 Mortimer C H Treatment of hair loss
JPS6118711A (ja) * 1984-07-05 1986-01-27 Pola Chem Ind Inc 養毛料
AU4805085A (en) * 1984-09-05 1986-03-24 Schering Aktiengesellschaft Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS62103005A (ja) * 1985-10-29 1987-05-13 Kanebo Ltd 養毛化粧料
DE3615396A1 (de) * 1986-05-07 1987-11-12 Wella Ag Mittel zur behandlung der haare und der kopfhaut
DE3621757A1 (de) * 1986-06-28 1988-01-14 Wella Ag Mittel zur behandlung der haare und der kopfhaut
DE4213314A1 (de) * 1992-04-23 1993-10-28 Ingeborg Zingraf Haarwasser und Haarbehandlungsverfahren zur Verringerung des Haarausfalls und Förderung des Haarwachstums bei androgenetischem Haarausfall

Also Published As

Publication number Publication date
AU3525395A (en) 1996-03-29
AU705118B2 (en) 1999-05-13
GB2295088B (en) 1998-11-25
WO1996008231A1 (en) 1996-03-21
EP0777458A1 (de) 1997-06-11
NZ292940A (en) 1998-12-23
GB9518725D0 (en) 1995-11-15
DE69519582D1 (de) 2001-01-11
EP0777458B1 (de) 2000-12-06
GB2295088A (en) 1996-05-22
JPH10508828A (ja) 1998-09-02
CA2200085A1 (en) 1996-03-21
US6020327A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
ATE197889T1 (de) Kontrolle des haarwuchses
DE69533360D1 (de) Enthaarungsverfahren
DE69510696D1 (de) 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)-benzopyran für die behandlung von proliferativer erkrankungen
ATE332687T1 (de) Liponsäure in topischen mittel
ATE253346T1 (de) Gerät zum aktivieren des natürlichen herzens
DE69526103D1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE59205037D1 (de) Vorrichtung zur behandlung von entzündlichen, sich im anfangsstadium befindlichen hautveränderungen
FI972093A0 (fi) Jäteveden käsittelymenetelmä ja -laitos
SE8403215D0 (sv) Neutralizing composition and method for hair waving and straightening
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
RU94015599A (ru) Применение n - ацетил-l - цистеина и его производных для регулирования образования морщин кожи и/или атрофии кожи, композиция на основе n - ацетил - l - цистеина и его производных
ES2088141T3 (es) Tratamiento de material de biomasa.
DK0632723T3 (da) Anvendelse af transglutaminase-inhibitor til behandling af arvæv
DE60212613D1 (de) Doxycyclin zur behandlung von akne
DE69232205D1 (de) Haarbehandlungszusammensetzung
AU7159794A (en) Treating water for dermatoses in domestic animals
NZ506681A (en) Disinfecting composition
DE60118591D1 (de) Kosmetische hautbehandlungsmethode
NO961550D0 (no) Fremgangsmåte og preparat for ökning av biocidisk aktivitet
ATE226058T1 (de) Verwendung von lysin zur behandlung des haarausfalls
BR9915914A (pt) Processo para a crio-conservação de plantas
SE9301606D0 (sv) Composition for the treatment of impaired hair growth
DE69519681D1 (de) Behandlung von tieren
EA199900174A1 (ru) Способ лечения биполярного расстройства